Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease.
(Q40464992)
scientific article published on January 2005
scientific article published on January 2005
Language: